| Autor: |
I M, Kakhnovskiĭ, V F, Marinin, S V, Arkhipova, L A, Sorokina, G K, Makhnach |
| Rok vydání: |
1998 |
| Předmět: |
|
| Zdroj: |
Terapevticheskii arkhiv. 70(9) |
| ISSN: |
0040-3660 |
| Popis: |
To investigate efficiency of inhacort in long-term (6 months to 2 years) treatment of bronchial asthma (BA).67 inpatients and 65 outpatients with moderate BA were divided into two groups. 96 patients of group 1 had received standard combined treatment without glucocorticosteroids (GCS), 36 patients of group 2 had received GCS. Inpatients were given inhacort in a dose 1000 micrograms/day, outpatients took inhacort in a daily dose 500 micrograms/day. The examination scheme included assessment of external respiration function (ERF), blood hydrocortisone, sputum rheology and diagnosis of candidosis.Inhacort treatment has reduced frequency of asphyxia attacks 2.5-fold 30 and 25% of the patients stopped taking sympathomimetics and GCS, respectively. None of the patients had asphyxia as a status. ERF, sputum viscosity improved, hydrocortisone secretion was unchanged. Only 3.8% of the patients developed oral candidosis.Inhacort in a dose 1 mg controls BA. 73% of the patients treated outpatiently had no need in hospitalization. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
